RHODE ISLAND: AIDS Hot Line Goes Silent at Year's End CDC Daily UpdateImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




RHODE ISLAND: AIDS Hot Line Goes Silent at Year's End

Providence Journal (12.27.04) - Thursday, December 30, 2004
Felice J. Freyer


On Dec. 31, the state's AIDS hot line, in operation for 18 years, will go dead. At its peak a decade ago, the hot line received as many as 5,000 calls annually. This year, barely 500 calls came in. The state Health department decided not to seek renewal of the federal grant that funds the hot line, operated by its founder, AIDS Project Rhode Island.

Although AIDS is not under control and the spread of HIV has not stopped, information about HIV/AIDS is more readily available, and many people seek answers to their questions on the Internet.

The grant that will not be renewed paid $48,000, a small but critical component of the APRI's $1.5 million budget, according to Executive Director Christopher A. Butler. Part of the money went to the agency's speakers' bureau to pay stipends to HIV-positive people to speak to students in middle schools and high schools. The agency has decided to keep its prevention director, who was paid from the grant, and to seek other sources of funds to keep the speakers' bureau in operation.

After Dec. 31, callers who phone the hot line during business hours will reach the agency's reception desk. People answering the phone will undergo additional training to answer hot line questions, Butler said. After hours, callers will be referred to the national AIDS hot line (800-342-AIDS), run by CDC.
041230
AD042635


Copyright © 2004 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.